Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Aug 5;58(8):1057.
doi: 10.3390/medicina58081057.

Bilateral Seminal Vesicle Invasion Is Not Associated with Worse Outcomes in Locally Advanced Prostate Carcinoma

Natalia Vidal Crespo  1 , Laura Enguita Arnal  2 , Álvaro Gómez-Ferrer  3 , Argimiro Collado Serra  3 , Juan Manuel Mascarós  3 , Ana Calatrava Fons  4 , Juan Casanova Ramón-Borja  3 , José Rubio Briones  3 , Miguel Ramírez-Backhaus  3
Affiliations
Observational Study

Bilateral Seminal Vesicle Invasion Is Not Associated with Worse Outcomes in Locally Advanced Prostate Carcinoma

Natalia Vidal Crespo et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Patients with seminal vesicle invasion (SVI) are a highly heterogeneous group. Prognosis can be affected by many clinical and pathological characteristics. Our aim was to study whether bilateral SVI (bi-SVI) is associated with worse oncological outcomes. Materials and Methods: This is an observational retrospective study that included 146 pT3b patients treated with radical prostatectomy (RP). We compared the results between unilateral SVI (uni-SVI) and bi-SVI. The log-rank test and Kaplan-Meier curves were used to compare biochemical recurrence-free survival (BCR), metastasis-free survival (MFS), and additional treatment-free survival. Cox proportional hazard models were used to identify predictors of BCR-free survival, MFS, and additional treatment-free survival. Results: 34.93% of patients had bi-SVI. The median follow-up was 46.84 months. No significant differences were seen between the uni-SVI and bi-SVI groups. BCR-free survival at 5 years was 33.31% and 25.65% (p = 0.44) for uni-SVI and bi-SVI. MFS at 5 years was 86.03% vs. 75.63% (p = 0.1), and additional treatment-free survival was 36.85% vs. 21.93% (p = 0.09), respectively. In the multivariate analysis, PSA was related to the development of BCR [HR 1.34 (95%CI: 1.01-1.77); p = 0.03] and metastasis [HR 1.83 (95%CI: 1.13-2.98); p = 0.02]. BCR was also influenced by lymph node infiltration [HR 2.74 (95%CI: 1.41-5.32); p = 0.003]. Additional treatment was performed more frequently in patients with positive margins [HR: 3.50 (95%CI: 1.65-7.44); p = 0.001]. Conclusions: SVI invasion is an adverse pathology feature, with a widely variable prognosis. In our study, bilateral seminal vesicle invasion did not predict worse outcomes in pT3b patients despite being associated with more undifferentiated tumors.

Keywords: biochemical recurrence; prostate cancer; radical prostatectomy; seminal vesicle invasion; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier curves showing BCR-free survival for both uni-SVI and bi-SVI groups.
Figure 2
Figure 2
Kaplan–Meier curves showing MFS for both uni-SVI and bi-SVI groups.
Figure 3
Figure 3
Kaplan–Meier curves showing additional treatment-free survival for both uni-SVI and bi-SVI groups.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Pierorazio P.M., Ross A.E., Schaeffer E.M., Epstein J.I., Han M., Walsh P.C., Partin A.V. A Contemporary Analysis of Outcomes of Adenocarcinoma of the Prostate with Seminal Vesicle Invasion (pT3b) After Radical Prostatectomy. J. Urol. 2011;185:1691–1697. doi: 10.1016/j.juro.2010.12.059. - DOI - PMC - PubMed
    1. Kristiansen A., Drevin L., Delahunt B., Samaratunga H., Robinson D., Lissbrant I.F., Stattin P., Egevad L. Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: A nationwide population-based study. Pathology. 2017;49:715–720. doi: 10.1016/j.pathol.2017.08.008. - DOI - PubMed
    1. Sapre N., Pedersen J., Hong M.K., Harewood L., Peters J., Costello A.J., Hovens C.M., Corcoran N.M. Re-evaluating the biological signifi cance of seminal vesicle invasion (SVI) in locally advanced prostate cancer. BJU Int. 2012;110:58–63. doi: 10.1111/j.1464-410X.2012.11477.x. - DOI - PubMed
    1. Epstein J.I., Partin A.W., Potter S.R., Walsh P.C. Adenocarcinoma of the Prostate Invading the Seminal Vesicle: Prognostic Stratification Based on Pathologic Parameters. Urology. 2000;56:283–288. doi: 10.1016/S0090-4295(00)00640-3. - DOI - PubMed
    1. Freedlan S.J., Aronson W.J., Presti J.C., Amling C.L., Terris M.K., Trock B., Kane C.J. Predictors of Prostate-Specific Antigen Progression among Men with Seminal Vesicle Invasion at the Time of Radical Prostatectomy. Cancer. 2004;100:1633–1638. doi: 10.1002/cncr.20122. - DOI - PubMed

Publication types

Substances